The performance of PSA testing in population screening is controversial due the fact that 20%–50% organ-confined cancer patients have less than 4 ng/mL of total PSA and many that have higher levels of PSA might not result in aggressive disease that kills the individual [41]. The gene discussed is KLK3; the disease is cancer.